Yearly Trends of Overactive Bladder Medication Usage.

Kevin J ChuaHiren V PatelAlexandra TabakinArnav SrivastavaSai Krishnaraya DoppalapudiElias HyamsHari Siva Gurunadha Rao Tunuguntla

Published in: Urology practice (2021)

Oxybutynin was consistently the most prescribed OAB medication every year. Mirabegron utilization steadily increased each year. Anticholinergic medications associated with fewer cognitive adverse effects, such as trospium, darifenacin and fesoterodine, were among the least prescribed.

Keyphrases

healthcare
adverse drug